Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
WASHINGTON PRIME GROUP INC. (WPG)
|
Add to portfolio |
|
|
|
| Price: |
$1.85
| | Metrics |
| OS: |
24.5
|
M
| |
-8
|
% ROE
|
| Market cap: |
$45.3
|
M
| |
|
% ROIC
|
|
Net debt:
|
$938
|
M
| |
4.4
|
x Debt/EBITDA
|
|
EV:
|
$983
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
$215
|
M
| |
4.6
|
x EV/EBITDA
|
|
EBIT
|
($5.6)
|
M
| |
|
|
| EPS |
($1.36)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 | Dec-31-13 |
| Revenues | 524.4 | 661.5 | 717.5 | 753.1 | 843.5 | 921.4 | 194.9 | 626.3 |
| Revenue growth | -20.7% | -7.8% | -4.7% | -10.7% | -8.5% | 372.8% | -68.9% | 0.4% |
| Cost of goods sold | 216.2 | 236.5 | 235.1 | 236.1 | 269.3 | 306.8 | 214.0 | 202.9 |
| Gross profit | 308.3 | 425.0 | 482.4 | 516.9 | 574.1 | 614.5 | -19.1 | 423.4 |
| Gross margin | 58.8% | 64.3% | 67.2% | 68.6% | 68.1% | 66.7% | -9.8% | 67.6% |
| Selling, general and administrative | | | | | | | 483.8 | |
| Sales and marketing | 7.3 | 9.5 | 9.1 | 9.1 | 10.4 | 11.6 | | 8.3 |
| General and administrative | 48.1 | 51.2 | 39.1 | 34.9 | 41.6 | 55.0 | | |
| EBIT | 31.2 | 253.8 | 300.5 | 512.2 | 297.5 | 212.1 | -502.9 | 228.4 |
| EBIT margin | 5.9% | 38.4% | 41.9% | 68.0% | 35.3% | 23.0% | -258.1% | 36.5% |
| Pre-tax income | -260.7 | 1.5 | 107.1 | 228.2 | 75.2 | -105.0 | 171.2 | 187.1 |
| Income taxes | 1.1 | -1.3 | -1.5 | -3.4 | -2.2 | -0.8 | 1.2 | -0.2 |
| Tax rate | | | | | | 0.8% | 0.7% | |
| Net income | -42.3 | -1.8 | 14.7 | 34.2 | 53.1 | -101.3 | 170.0 | 155.5 |
| Net margin | -8.1% | -0.3% | 2.1% | 4.5% | 6.3% | -11.0% | 87.2% | 24.8% |
| |
| Diluted EPS | ($2.00) | ($0.09) | $0.71 | $0.18 | $0.29 | ($0.55) | $1.10 | $1.00 |
| Shares outstanding (diluted) | 21.2 | 20.9 | 20.9 | 186.8 | 185.6 | 184.2 | 155.2 | 155.2 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|